Gastrointestinal bacterial infection represents a significant threat to human health, as well 12 as a burden on food animal production and welfare. Although there is advanced knowledge 13 about the molecular mechanisms underlying pathogenesis, including the development of 14 immune responses to these pathogens, gaps in knowledge persist. It is well established that 15 gastrointestinal bacterial pathogens produce a myriad of proteins that affect the 16 development and effectiveness of innate immune responses. However, relatively few 17 proteins that directly affect lymphocytes responsible for humoral or cell-mediated immunity 18 and memory have been identified. Here, we review factors produced by gastrointestinal 19 bacterial pathogens that have direct T cell interactions and what is known about their 20 functions and mechanisms of action. T cell interacting bacterial proteins that have been 21 identified to date mainly target three major T cell responses: activation and expansion, 22 chemotaxis or apoptosis. Further, the requirement for more focused studies to identify and 23 understand additional mechanisms used by bacteria to directly affect the T cell immune 24 response and how these may contribute to pathogenesis is highlighted. Increased 25 knowledge in this area will help to drive development of better interventions in prevention 26 and treatment of gastrointestinal bacterial infection.
Introduction
Gastrointestinal bacterial infection represents a significant threat to human health 30 and welfare, with an estimated 900 million illnesses resulting in over 500 000 deaths in a 31 single year, according to the World Health Organisation (1). Although much is known about 32 the molecular mechanisms underlying persistence, pathogenesis and protection, significant 33 effort is still required to devise effective intervention strategies. Bacterial immune evasion 34 methods include expression of surface polysaccharides to resist complement-mediated 35 killing and opsonisation, enzymes to detoxify reactive oxygen species in phagosomes, 36 escape from phagosomes and in the case of intracellular bacterial pathogens, interference 37 in cellular antigen-presentation and innate immune responses by proteins secreted by Type 38 III or Type IV secretion systems (2). The role of Type III secretion in gastrointestinal bacterial 39 pathogens is covered by many high quality reviews (eg. 3), and therefore is not the focus of 40 this review. Relatively fewer mechanisms have been identified whereby bacteria are able to 41 directly affect lymphocytes during infection. Further, understanding the full role of these 42 bacterial proteins and their T cell interactions during infections, any specificity for T cells 43 subsets, and proof that they are able to directly meet T cells in the body is crucial to 44 establish biological importance. However, such evidence is often lacking, and a number of 45 barriers to understanding these aspects exist. 46 Here, we review the known molecules and strategies that contribute to the direct 47 subversion or dampening of the adaptive T cell response in gastrointestinal bacterial 48 infection. In addition, we discuss the challenges and aspirations of identifying these 49 mechanisms. IELs appear to lack some typical T cell surface molecules such as CD2 (adhesion molecule), 76 on January 22, 2018 by UNIVERSITY OF EDINBURGH http://iai.asm.org/ Downloaded from 5 CD28 (activating co-receptor) and Thy-1 (pan T cell marker of human and mouse cells). 77 These cells are considered "activated, yet resting" and are different compared to peripheral 78 T cells (which express CD4 or CD8αβ isoform; reviewed in (4)). 79 Although there is not a large literature describing direct effects of gastrointestinal 80 bacterial pathogens on T cells, a picture of the general strategies used to alter T lymphocyte 81 function is emerging (summarised in Figure 2 ). The effects identified can be broadly 82 assigned to three groups: those that affect T cell activation and proliferation, those that 83 affect chemotaxis and those that cause elimination of T cells, with most of the strategies 84 identified thus far falling into the first category. Little duplication of specific strategies 85 across species of intestinal bacteria has been identified so far, and the mechanisms and 86 observations described are derived from a relatively small number of bacterial species.
87
Proteins that affect T cell activation and proliferation 88 A number of bacterial proteins have been identified that act to interfere with signalling 89 cascades in T cell activation and expansion, which are outlined below. These proteins are 90 often soluble, diffusible factors, and can act externally to the T cell, as well as intracellularly. Helicobacter pylori expresses the VacA vacuolating cytotoxin, which has direct prevent IL-2 expression by blocking translocation of the transcription factor NF-AT (24, 25). 173 Overall, the data suggest that VacA targets previously activated T cells. Using in vivo studies 174 in mice, a null mutation of vacA was reported to impair initial colonization of mice by H. Myc and IRF4 which are sensitive to glutamine, and required for metabolic adaptation (54). 237 Overall, the data suggest that GGT is able to modulate the response of T cells in infection, 238 likely through control of the extracellular availability of glutamine, which is required during 239 activation. 240 A second example of a gastrointestinal bacterial protein that interferes with T cell 241 metabolism comes from Salmonella enterica serovar Typhimurium, which has been 242 reported to directly inhibit primary mouse T cells (55), and is thought to limit availability of 243 asparagine to T cells (56). When assessing a number of cell surface expressed molecules, no 12 difference was noted in levels of CD69, CD25α, CD44, and CD62L in cells infected with S. 245 Typhimurium compared to uninfected controls. However, in the presence of S. 246 Typhimurium, neither IL-2 nor IFN-γ were produced with CD3 cross-linking (both these 247 cytokines are up-regulated during T cell activation). Cytokine production was restored if the 248 cells were separated from the bacteria in a transwell arrangement, indicating that direct 249 contact with the bacteria was required for this effect. From here, the authors extended 250 their observations, again using in vitro methods with primary mouse cells, showing that S. 251 Typhimurium was able to down regulate surface expression the TCR β chain, resulting in 252 decreased gene expression, intracellular and surface protein, at least partially explaining the 253 mechanism targeted to inhibit T cell activation (57). Not only that, but this effect was only 254 observed in the presence of live bacteria, as treatment with heat-inactivated bacteria 255 abrogated this effect. The effects were shown to be unrelated to Type III secretion or the 256 bacterial virulence plasmid. It was later shown that the protein responsible for this was L-257 asparaginase II (STM3106; asnB) (58). In a mouse model of bacterial persistence, the burden 258 of bacteria was lower in mutants lacking L-asparaginase II, suggesting that this molecule 259 may enable bacterial persistence by dampening the T cell-mediated immune response (58). 260 In contrast, in a screen of S. Typhimurium mutants in pigs, calves and chickens, a transposon 261 insertion was not attenuating in the gut, albeit within 3-4 days after oral infection (59). 262 Nonetheless, the characterization of the activity of the L-asparaginase II on T cells is a good 263 example of how bacterial subversion can lead to insight into basic host cell biology. In this 264 case these studies highlight the importance of asparagine as a nutrient in T cell metabolism 265 and activation (60). vitro treatment of cells did not entirely reflect the in vivo effects observed (70). In addition, 312 the maturation state of the T cell appears to determine the mechanism of apoptosis 313 triggered (71). Further, although CT does not appear to invoke apoptosis in CD4+ T cells, it does appear to be able to inhibit activation, at least based on measurement of cell surface 315 expressed molecules (69). 316 There has been significant interest in using CT and LT as adjuvants in vaccination, and 317 understanding how it is able to steer T cell responses provides insight in how to better 318 improve vaccination, or to engineer non-toxic derivatives that are able to promote its 319 adjuvancy (72-75). 
